Michael Böhmig

Prospective, Randomized, Multicenter Trial on the Antiproliferative Effect of Lanreotide, Interferon Alfa, and Their Combination for Therapy of Metastatic Neuroendocrine Gastroenteropancreatic Tumors—The International Lanreotide and Interferon Alfa Study Group

Siegbert Faiss, Ulrich‐Frank Pape, Michael Böhmig et al. · Journal of Clinical Oncology · 2003 · 497 citations

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours

U.-F. Pape, Uta Berndt, Jacqueline Müller‐Nordhorn et al. · Endocrine Related Cancer · 2008 · 381 citations · Full text

Prospective Evaluation of Pancreatic Tumors: Accuracy of MR Imaging with MR Cholangiopancreatography and MR Angiography

Enrique Lopez Hänninen, Holger Amthauer, Norbert Hosten et al. · Radiology · 2002 · 155 citations

Survival and Clinical Outcome of Patients with Neuroendocrine Tumors of the Gastroenteropancreatic Tract in a German Referral Center

U.-F. Pape, Michael Böhmig, Uta Berndt et al. · Annals of the New York Academy of Sciences · 2004 · 135 citations

Reduced incidence of esophageal lesions by luminal esophageal temperature–guided second-generation cryoballoon ablation

Alexander Fürnkranz, Stefano Bordignon, Michael Böhmig et al. · Heart Rhythm · 2014 · 117 citations

Esophagus, Esophageal Cancer, Luminal Esophageal +3